We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Oruba Showcases Innovative Self-Operating Uroflowmeter

By LabMedica International staff writers
Posted on 12 Nov 2024

Oruba Technology & Innovation (Langenfeld, Germany) is showcasing its innovative self-operating uroflowmeter, Oruflow, including both the urinal and toilet versions, at MEDICA 2024. More...

Oruflow is the world’s first self-operating uroflowmeter. As a point-of-care (POC) diagnostic device, it eases and accelerates the uroflowmetry process in a hygienic and comfortable atmosphere, making it a crucial part of every hospital and urology clinic. Oruba Oruflow is available in two versions for urology clinics – the Oruflow i POC diagnostic urinal and the Oruflow h POC diagnostic toilet. Both the devices feature an on-board screen to assist patients before and after examinations. The patient can receive the results of the examination in seconds without any operator guidance. The patient uses the hospital barcode to let Oruba Oruflow save the examination report into the hospital information system automatically.

The Oruflow h features a specially designed adapter enabling accurate and comfortable uroflowmetry testing for individuals of all gender types and ages. This ergonomic adapter is designed to accommodate anatomical differences such as the urination posture of women, ensuring a seamless and user-friendly experience. This adaptor is also suitable for children, providing the same level of comfort and accuracy. Oruflow h introduces a groundbreaking feature: The anatomical design of the toilet which separates stool and urine. With this feature, Oruflow h continues working even after accidental defecation, ensuring reliable performance in all conditions.

Both the Oruflow models have an EMG (electromyography) option, which provides synchronized uroflowmetry and EMG measurements. While the Oruflow measures the urine flow rate, the EMG module measures the electrical activity of the muscles before, during, and after urination to evaluate urinary problems. In biofeedback, EMG results are displayed using a bird game interface which is also virtual reality-compatible. When the patient contracts their muscles, the bird flaps. The doctor can change the scale and see the results synchronously.

Related Links:
Oruba Technology & Innovation


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.